IS4459A - New peptides are immune-modifying - Google Patents

New peptides are immune-modifying

Info

Publication number
IS4459A
IS4459A IS4459A IS4459A IS4459A IS 4459 A IS4459 A IS 4459A IS 4459 A IS4459 A IS 4459A IS 4459 A IS4459 A IS 4459A IS 4459 A IS4459 A IS 4459A
Authority
IS
Iceland
Prior art keywords
immune
modifying
new peptides
peptides
new
Prior art date
Application number
IS4459A
Other languages
Icelandic (is)
Inventor
Bergstrand Håkan
Eriksson Tomas
Karabelas Kostas
Lindvall Magnus
Särnstrand Bengt
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of IS4459A publication Critical patent/IS4459A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IS4459A 1994-10-14 1997-04-08 New peptides are immune-modifying IS4459A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9403526A SE9403526D0 (en) 1994-10-14 1994-10-14 New Peptides
PCT/SE1995/001151 WO1996011943A1 (en) 1994-10-14 1995-10-06 New peptides with immunomodulatory effects

Publications (1)

Publication Number Publication Date
IS4459A true IS4459A (en) 1997-04-08

Family

ID=20395628

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4459A IS4459A (en) 1994-10-14 1997-04-08 New peptides are immune-modifying

Country Status (20)

Country Link
US (2) US6103697A (en)
EP (1) EP0783519A1 (en)
JP (1) JPH10507448A (en)
AU (1) AU705364B2 (en)
BR (1) BR9509345A (en)
CA (1) CA2201479A1 (en)
CZ (1) CZ111997A3 (en)
EE (1) EE9700087A (en)
FI (1) FI971499A (en)
HU (1) HUT77118A (en)
IL (1) IL115509A0 (en)
IS (1) IS4459A (en)
MX (1) MX9702666A (en)
NO (1) NO971625L (en)
PL (1) PL319631A1 (en)
SE (1) SE9403526D0 (en)
SK (1) SK46797A3 (en)
TR (1) TR199501255A2 (en)
WO (1) WO1996011943A1 (en)
ZA (1) ZA958140B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403526D0 (en) 1994-10-14 1994-10-14 Astra Ab New Peptides
SE9501067D0 (en) 1995-03-24 1995-03-24 Astra Ab New peptides
WO1997039023A1 (en) * 1996-04-12 1997-10-23 Astra Aktiebolag Cysteine-containing or methioine-containing peptides with immunomodulatory effects
WO1998001147A1 (en) * 1996-07-08 1998-01-15 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
SE9603463D0 (en) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603467D0 (en) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603468D0 (en) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603466D0 (en) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603465D0 (en) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603461D0 (en) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603462D0 (en) * 1996-09-23 1996-09-23 Astra Ab New compounds
WO1999019347A1 (en) * 1997-10-10 1999-04-22 Astrazeneca Ab Synthetic genes with immunomodulatory effects
EP1083872A1 (en) * 1998-06-03 2001-03-21 GPI NIL Holdings, Inc. Pipecolic acid derivative hair growth compositions and uses
RU2144374C1 (en) * 1998-11-23 2000-01-20 Закрытое акционерное общество "ВАМ" Method of preparing of oxidized glutathione-cis- diaminodichloroplatinum complex and pharmaceutical compositions based on this complex for controlling metabolism, proliferation, and differentiation, and mechanisms of apoptosis of normal and transformated cells
JP4711520B2 (en) * 2000-03-21 2011-06-29 日本ケミカルリサーチ株式会社 Bioactive peptide-containing powder
US7265208B2 (en) * 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
US8080560B2 (en) 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
GB2442408B (en) 2005-04-25 2010-06-30 Cadila Pharmaceuticals Ltd Mycobacterium W as an adjuvant
KR101363455B1 (en) 2011-09-09 2014-02-21 (주)케어젠 Peptides Inhibiting the Activity of Matrix Metalloproteases and Use Thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
AU1366088A (en) 1987-01-28 1988-08-24 Ortho Pharmaceutical Corporation Immunosuppressive peptides and methods of use
FR2622700B1 (en) 1987-10-30 1993-08-13 Aderegem PROTEIN AND ITS FRAGMENTS REPRESENTING THE SPECIFIC EXPRESSION OF THE PS2 GENE OF BREAST CANCERS, ANTIBODIES OBTAINED FROM SAID PROTEIN AND / OR FRAGMENTS THEREOF, THEIR APPLICATIONS FOR THE DETECTION AND DIAGNOSIS OF BREAST CANCERS
EP0341603A3 (en) * 1988-05-09 1990-07-04 Abbott Laboratories Atrial peptide derivatives
US5223485A (en) * 1989-01-31 1993-06-29 Abbott Laboratories Anaphylatoxin-receptor ligands
JP2596466B2 (en) 1990-03-03 1997-04-02 アサヒビール株式会社 DNA having transfer information of major allergen of mite and method for producing the allergen
KR100274321B1 (en) 1990-09-11 2000-12-15 스미드 이. 그레이엄 Cloning and sequencing of allergens of dermatophagoids (house dust mite)
WO1993000108A1 (en) * 1991-06-28 1993-01-07 Corvas International, Inc. Novel inhibitors of platelet aggregation
JP2657861B2 (en) 1991-09-17 1997-09-30 アサヒビール株式会社 Method for producing major mite allergen
DE69233772D1 (en) 1991-10-16 2009-11-12 Merck Patent Gmbh T-CELL EPITOPES OF THE MOST IMPORTANT ALLERGENS OF DERMATOPHAGOIDES (HAUSMILBE)
JP3149033B2 (en) 1991-10-30 2001-03-26 アサヒビール株式会社 Peptides in the mite major allergen Der f II
CA2157510A1 (en) 1993-03-05 1994-09-15 Howard M. Grey Hla-a2.1 binding peptides and their uses
IL106214A (en) * 1993-07-01 1998-12-06 Yeda Res & Dev Thf-gamma2 analogs and pharmaceutical compositions comprising them
JPH07215996A (en) 1994-01-31 1995-08-15 Torii Yakuhin Kk B cell epitope against mite allergen
AP690A (en) 1994-07-05 1998-10-16 Steeno Res Group A/S Immunomodulators based on a polypeptide other than human interleukin 10.
SE9403526D0 (en) 1994-10-14 1994-10-14 Astra Ab New Peptides

Also Published As

Publication number Publication date
US6228374B1 (en) 2001-05-08
WO1996011943A1 (en) 1996-04-25
ZA958140B (en) 1997-06-27
CZ111997A3 (en) 1997-12-17
SE9403526D0 (en) 1994-10-14
AU3713395A (en) 1996-05-06
NO971625D0 (en) 1997-04-09
SK46797A3 (en) 1997-09-10
FI971499A0 (en) 1997-04-10
EE9700087A (en) 1997-10-15
IL115509A0 (en) 1996-05-14
BR9509345A (en) 1997-11-25
NO971625L (en) 1997-05-30
US6103697A (en) 2000-08-15
JPH10507448A (en) 1998-07-21
CA2201479A1 (en) 1996-04-25
EP0783519A1 (en) 1997-07-16
FI971499A (en) 1997-06-10
HUT77118A (en) 1998-03-02
AU705364B2 (en) 1999-05-20
TR199501255A2 (en) 1996-06-21
MX9702666A (en) 1997-06-28
PL319631A1 (en) 1997-08-18

Similar Documents

Publication Publication Date Title
ATA166795A (en) BIS-RESORCINYLTRIAZINE
ATA147195A (en) ALKOXYPHENYL-SUBSTITUTED BISBENZOYLPHOSPHINOXIDE
ATA163695A (en) 2-HYDROXYPHENYLTRIAZINE
NO985680D0 (en) peptide
IS4459A (en) New peptides are immune-modifying
BR9508433A (en) Peptides
NO983849L (en) peptide
ATA108995A (en) DIFFERENZDRUCKAKKUMULATOR
TR199701666A3 (en) Proteins
FI970744A (en) New immunosuppressive peptides
ATA11894A (en) STAUFÖRDERBAHN
FIU940170U0 (en) Stoedram
KR950024232U (en) Improvement case
KR950032123U (en) Improvement
KR960003039U (en) Improved Pharmaroy
BR7400683U (en) Odontoportable
FI1360U1 (en) Justerbar details
DK1017798T3 (en) lunasin peptides
NO20000976D0 (en) peptides
KR960009026U (en) every
KR960022698U (en) Improvement
KR950026631U (en) Improvement
KR950026546U (en) Improvement
BR9402348A (en) Improved Passaguá
ATE197372T1 (en) PRE-DOUGH